학술논문

1 . Academic Journal

Efficacy, safety, and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of care in chronic hepatitis B patients

저자: by Hou, Jinlin; Gane, Edward; Balabanska, Rozalina; Zhang, Wenhong; Zhang, Jiming, et al.
소스: Clinical and Molecular Hepatology. 30(2):191-205

7 . Academic Journal

Efficacy, safety, and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of care in chronic hepatitis B patients

저자: by Yuen, Man-Fung; Zhang, Wen; Triyatni, Miriam; Zhou, Xue; Bo, Qingyan, et al.
소스: Clinical and Molecular Hepatology. 30(2):191-205

7 . Academic Journal

Safety, pharmacokinetics, and antiviral activity of RO7049389, a core protein allosteric modulator, in patients with chronic hepatitis B virus infection: a multicentre, randomised, placebo-controlled, phase 1 trial

저자: by Yuen, Man-Fung; Zhou, Xue; Gane, Edward; Schwabe, Christian; Tanwandee, Tawesak, et al.
소스: In The Lancet Gastroenterology & Hepatology September 2021 6(9):723-732

7 . Academic Journal

LBP-021 Prolonged reduction of hepatitis B surface antigen in virologically suppressed participants treated with concurrent or sequential use of pegylated interferon alpha with xalnesiran-based therapy: results after 120 weeks of follow-up of an observational study

저자: by Liang, Xieer; Liu, Zhihong; Lai, Qintao; Peng, Jie; Lu, Aili, et al.
소스: In Journal of Hepatology May 2025 82 Supplement 1:S80-S80

7 . Academic Journal

SAT427 - Viral nucleic acids suppression activity of RO7049389 plus NUC with/without Peg-IFN in virologically-suppressed and naive chronic hepatitis B patients: 48-week treatment and post-treatment follow-up

저자: by Yuen, Man-Fung; Balabanska, Rozalina; Hou, Jinlin; Gane, Edward J; Lim, Tien Huey, et al.
소스: In Journal of Hepatology July 2022 77 Supplement 1:S867-S867

7 . Academic Journal

THU408 - Hepatitis B virus antigen reduction effect of RO7049389 plus NUC with/without Peg-IFN in chronic hepatitis B patients

저자: by Hou, Jinlin; Gane, Edward J; Zhang, Wenhong; Zhang, Jiming; Yuen, Man-Fung, et al.
소스: In Journal of Hepatology July 2022 77 Supplement 1:S299-S299

7 . Academic Journal

SAT395 - Resistance monitoring data from treatment-naive chronic HBV infected patients treated for 28 days with a new class a core protein allosteric modulator RO7049389 monotherapy

저자: by Zhou, Xue; Kazma, Rémi; Meinel, Dominik; Zhou, Yuan; Yuen, Man-Fung, et al.
소스: In Journal of Hepatology August 2020 73 Supplement 1:S850-S851

7 . Academic Journal

FRI-219-RO7049389, a core protein allosteric modulator, demonstrates robust decline in HBV DNA and HBV RNA in chronic HBV infected patients

저자: by Gane, Edward; Yuen, Man-Fung; Bo, Qingyan; Schwabe, Christian; Tanwandee, Tawesak, et al.
소스: In Journal of Hepatology April 2019 70(1) Supplement:e491-e491

7 . Academic Journal

Evaluation of the safety, tolerability, and pharmacokinetics of RO7049389 in healthy Chinese volunteers.

저자: by Wu, Xiaojie; Feng, Sheng; Zhang, Jing; Zhang, Wenhong; Zhang, Yuchen, et al.
소스: CTS: Clinical & Translational Science. Jan2022, Vol. 15 Issue 1, p195-203. 9p.

7 . Academic Journal

Further Evaluation of Coproporphyrins as Clinical Endogenous Markers for OATP1B.

저자: by Feng, Sheng; Bo, Qingyan; Coleman, Hugh A.; Charoin, Jean Eric; Zhu, Mingfen, et al.
소스: Journal of Clinical Pharmacology. Aug2021, Vol. 61 Issue 8, p1027-1034. 8p.

공지

DAU Library